Table 4 Outcome of anti-NMDAR encephalitis patients with or without ovarian teratoma
From: Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases
Histological type of teratoma | OUTCOME | Time to discharge or partial recovery (N), median (m-m) m ± SD (months) | ||
|---|---|---|---|---|
Recovery N (%) | Partial recovery N (%) | Died N (%) | ||
Mature (99) | 87(87,9) | 8(8,1) | 4(4,0) | (47), 3(0,5-12), 3,1 ± 2,0 |
Immature (29) | 22(75,9) | 5(17,2) | 2(6,9) | (9), 3,5(0,7-11), 4,3 ± 3,4 |
Mature + Immature (6) | 4(66,7) | 1(16,7) | 1(16,7) | (3), 4(3-6), 4,3 ± 1,5 |
Not specified (40) | 29(72,5) | 6(15,0) | 5(12,5) | (11), 3(1-24), 5,0 ± 6,4 |
Total with teratoma (174) | 142(81,6) | 20(11,5) | 12(6,9) | (70), 3(0,5-24), 3,6 ± 3,2 |
Ovarian teratoma not found (40) | 34(85)* | 3(7,5) | 1(2,5) | (10), 5,5(1-14), 5,7 ± 3,7+ |